IP Library › Granted Patent US 12,152,035
Granted Patent B2
US 12,152,035 · App. 17/561,055 · Granted Nov 26, 2024

Androgen receptor binding molecule and use thereof

Inventors: Chih-Wei Fu (Taoyuan, TW); Hao-Hsuan Liu (Taichung, TW); Chiu-Lien Hung (Kaohsiung, TW); Yu-Chin Lin (Taichung, TW); Tsan-Lin Hu (Jhubei, TW); Chien-Chin Huang (Yizhu Township, TW)
Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
C07D487/04A61P35/00C07D401/04C07D417/12C07D417/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,152,035
App. No.
17/561,055
Granted
Nov 26, 2024
Kind
B2
Abstract

An androgen receptor (AR) binding molecule has the structure of Formula (I) shown in the following: wherein E is CH 2 , G is CH, is OH, NH 2 , OTf or C≡C, X is CF 3 or trifluoromethylphenyl, is a single bond, and Y and Z are CH 2 ; or is absent, X is CF 3 , is a double bond, and Y and Z are CH.

Claims (119)

1. A compound selected from the group consisting of the compounds as shown below:

Com-

pound

number

Structure

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

2. A method for treating prostate cancer comprising:

administering a compound to a subject in need thereof to treat prostate cancer in the subject,

wherein the compound is selected from the group consisting of the compounds as shown below:

Com-

pound

number

Structure

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

3. The method for treating prostate cancer as claimed in claim 2 , wherein the prostate cancer is prostate cancer with full length androgen receptor and/or androgen receptor splice variant 7.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2022
From: FU, CHIH-WEI; LIU, HAO-HSUAN; HUNG, CHIU-LIEN; LIN, YU-CHIN; HU, TSAN-LIN; HUANG, CHIEN-CHIN
To: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
Reel/Frame 059457/0679 →
Continuity (2)
Provisional Application 63131984 · Dec 30, 2020
Related Publication 20220227771A1 · Jul 21, 2022